SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-10-009096
Filing Date
2010-02-19
Accepted
2010-02-19 17:14:05
Documents
1
Period of Report
2010-02-12

Document Format Files

Seq Description Document Type Size
1 v175059_ex.html 4  
1 v175059_ex.xml 4 9193
  Complete submission text file 0001144204-10-009096.txt   11073
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GOHEN IS RETACH TIKVA L3 00000
Business Address
STOLICK DAVID (Reporting) CIK: 0001318693 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-61610 | Film No.: 10620369